LLCB - Laboratory of Lymphatic and Cancer Bioengineering
16:33Elucidating the role of lymphatic vessels within the tumor microenvironment of breast cancer. Thèse EPFL, n° 7522 (2017)
23:41Primary human and rat beta cells release the intracellular autoantigens GAD65, IA-2 and proinsulin in exosomes together with cytokine-induced enhancers of immunity, in Diabetes, vol. 66, num. 2, p. 460-473, 2017.
14:37Lymphatic vessels regulate immune microenvironments in human and murine melanoma, in Journal Of Clinical Investigation, vol. 126, num. 9, p. 3389-3402, 2016.
16:49Engineering Lymphangiogenesis: Implications for Cancer Immunotherapy and Beyond. Thèse EPFL, n° 7047 (2016)
12:08Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses, in Vaccine, vol. 34, num. 21, p. 2453-2459, 2016.
17:31Polypropylene Sulfide Nanoparticle p24 Vaccine Promotes Dendritic Cell-Mediated Specific Immune Responses against HIV-1, in Journal of Investigative Dermatology, vol. 136, num. 6, p. 1172-1181, 2016.
15:18New immunomodulatory roles of lymphatic endothelium and implications for immunotherapy. Thèse EPFL, n° 6967 (2016)
12:48A Cationic Micelle Complex Improves CD8+T Cell Responses in Vaccination Against Unmodified Protein Antigen, in Acs Biomaterials-Science & Engineering, vol. 2, num. 2, p. 231-240, 2016.
10:22Engineering opportunities in cancer immunotherapy, in Proceedings Of The National Academy Of Sciences Of The United States Of America, vol. 112, num. 47, p. 14467-14472, 2015.
14:52Engineering nanoparticle-based vaccines: Implications for the quality of humoral and cellular immunity. Thèse EPFL, n° 6848 (2016)